Silvio O. Conte Center for Stress Peptide Advanced Research, Education, & Dissemination (SPARED) at McLean Hospital
Silvio O. Conte 应激肽高级研究、教育中心,
基本信息
- 批准号:10116474
- 负责人:
- 金额:$ 271.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2024-02-28
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAnxiety DisordersAutopsyBiologicalBiologyBrainCellsChemicalsClinicalCollaborationsCollectionCommunicationCommunitiesComplementCorticotropin-Releasing HormoneData SetDevelopmentDiagnosticDimensionsDiseaseEducationEducation and OutreachEducational ActivitiesEducational MaterialsElementsFuture GenerationsGoalsGrowthHealthHospitalsHumanIndividualInternetInvestigationKnowledgeLearningMental disordersMolecularMood DisordersMusMutationNeurobiologyPathologicPathway interactionsPeptidesPersonsPhenotypePhysiologicalPost-Traumatic Stress DisordersResearchResearch Domain CriteriaResearch PersonnelResourcesRoleSamplingScienceScientistServicesStressSystemTechnologyTestingTherapeuticTraining ActivityTraining and EducationTranslatingWorkbasebehavior measurementcareercareer developmentclinical carecohesiondigitalimprovedinnovationinsightinterestmultidisciplinarynewsnovel therapeutic interventionnovel therapeuticsoutreachoutreach programpeptidomimeticspituitary adenylate cyclase activating polypeptidepre-clinicalprecision medicineresponsesocial mediastress related disordersynergismweb site
项目摘要
SUMMARY: SPARED CENTER
The Silvio O. Conte Center for Stress Peptide Advanced Research, Education, & Dissemination (SPARED) at
McLean Hospital will combine world-renowned preclinical and clinical researchers in the field of stress biology
to comprehensively examine, compare, and contrast the neurobiological effects of CRF (Corticotropin-Releasing
Factor) and PACAP (Pituitary Adenylate Cyclase-Activating Polypeptide), two peptides with well-validated roles
in the biology of stress-related conditions. Genetic alterations in these systems render people more vulnerable
to stress, administration of either peptide mimics key stress effects, and both systems are altered by stress.
Their high degree of conservation across species suggests that each regulates equally important—yet subtly
different—aspects of stress responsiveness. Indeed, a major difference revealed by animal models is that the
stressful effects of PACAP system activation tend to be more persistent than those of CRF system activation.
The scientific elements include complementary molecular, cellular, circuit, physiologic, and behavioral measures
in mice and humans, as well as detailed hypothesis testing in postmortem brain samples obtained from
individuals with Post-Traumatic Stress Disorder (PTSD) and healthy controls. To complement the science, the
Center will also support a broad range of training and educational activities, including expansion of outreach
programs as well as social media approaches to engage scientists and lay-persons. Our overall Aims provide
the basis for synergy that will transform this work from a collection of individual projects into a cohesive Center
where each element enriches, and is enriched by, the activities of the others, serving as a resource that benefits
the scientific community and beyond. Aim 1 (Collaboration) is to bring together leading researchers who are
committed to understanding stress and reducing its health burdens by combining new insights on biology with
cutting-edge technologies, and establish a framework that enables sustained collaboration in the service of
advancing discovery and innovation. Aim 2 (Investigation) is to use a multidisciplinary, RDoC-compatible
approach to conduct high-impact research that transforms our mechanistic understanding of CRF and PACAP
systems to facilitate the development of improved diagnostics and therapeutics for a range of DSM-defined
disorders that are caused or exacerbated by stress. Aim 3 (Outreach) is to implement unique and impactful
approaches that enhance education, training, and career development for future generations of translationally-
oriented stress researchers. Aim 4 (Innovation) is to use information and internet technologies to transform
collaboration, investigation, and outreach to achieve broad communication of Center-related activities, including
sharing of educational materials and strategies, nimbly disseminating news, and making available data sets.
Pursuit of these goals will establish the SPARED Center as a unique resource for elucidating the brain
mechanisms underlying stress-induced psychiatric disorders, translating this knowledge to clinical care, and
disseminating our findings in ways that will resonate with experts as well as the lay-public.
摘要:幸存的中心
Silvio O. Conte 应激肽高级研究、教育和传播中心 (SPARED),位于
麦克莱恩医院将联合应激生物学领域世界知名的临床前和临床研究人员
全面检查、比较和对比 CRF(促肾上腺皮质激素释放)的神经生物学效应
因子)和 PACAP(垂体腺苷酸环化酶激活多肽),两种具有充分验证作用的肽
在与压力相关的条件的生物学中。这些系统的基因改变使人们更加脆弱
对于压力,任何一种肽的施用都会模拟关键的压力效应,并且这两个系统都会因压力而改变。
它们在不同物种之间的高度保护表明,每个物种的调节同样重要——但微妙
压力反应的不同方面。事实上,动物模型揭示的一个主要区别是
PACAP 系统激活的压力效应往往比 CRF 系统激活的压力效应更持久。
科学要素包括互补的分子、细胞、电路、生理和行为测量
在小鼠和人类中,以及从死后大脑样本中获得的详细假设检验
患有创伤后应激障碍(PTSD)的人和健康对照者。为了补充科学,
中心还将支持广泛的培训和教育活动,包括扩大外展范围
项目以及社交媒体方法来吸引科学家和非专业人士的参与。我们的总体目标提供
协同作用的基础,将把这项工作从单个项目的集合转变为一个有凝聚力的中心
其中每个要素都丰富了其他要素的活动,并被其他要素的活动所丰富,成为造福人类的资源
科学界及其他领域。目标 1(合作)是将以下领域的领先研究人员聚集在一起
致力于通过将生物学的新见解与
尖端技术,并建立一个能够持续合作的框架
推进发现和创新。目标 2(调查)是使用多学科、RDoC 兼容的方法
进行高影响力研究的方法,改变我们对 CRF 和 PACAP 的机制理解
系统,以促进针对一系列 DSM 定义的改进诊断和治疗的开发
由压力引起或加剧的疾病。目标 3(外展)是实施独特且有影响力的
加强未来几代转化者的教育、培训和职业发展的方法
面向压力研究人员。目标4(创新)是利用信息和互联网技术进行变革
协作、调查和外展,以实现中心相关活动的广泛沟通,包括
共享教育材料和策略、灵活传播新闻并提供可用的数据集。
追求这些目标将使 SPARED 中心成为阐明大脑的独特资源
压力诱发精神疾病的机制,将这些知识转化为临床护理,以及
以引起专家和公众共鸣的方式传播我们的研究结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
William A. Carlezon其他文献
Dérivés de salvinorine et leurs utilisations
萨尔维诺林及其用途的衍生品
- DOI:
- 发表时间:
2009 - 期刊:
- 影响因子:0
- 作者:
C. Béguin;Justin S. Potuzak;T. Munro;Kath Duncan;William A. Carlezon;Bruce M. Cohen;Lee - 通讯作者:
Lee
Super glue: emerging roles for non-neuronal brain cells in mental health
强力胶:非神经元脑细胞在心理健康中的新兴作用
- DOI:
10.1038/s41386-021-01115-1 - 发表时间:
2021-07-26 - 期刊:
- 影响因子:7.100
- 作者:
William A. Carlezon;Galen Missig - 通讯作者:
Galen Missig
Inflammatory pain in mice induces light cycle-dependent effects on sleep architecture
小鼠的炎症性疼痛诱导对睡眠结构的光周期依赖性效应
- DOI:
10.1038/s41386-025-02152-w - 发表时间:
2025-06-22 - 期刊:
- 影响因子:7.100
- 作者:
Dominika J. Burek;Khairunisa Mohamad Ibrahim;Andrew G. Hall;Ashish Sharma;Jessica A. Cucinello-Ragland;Erik S. Musiek;Jose A. Morón;William A. Carlezon - 通讯作者:
William A. Carlezon
Ascent of the kappa-opioid receptor in psychopharmacology
- DOI:
10.1007/s00213-010-1849-0 - 发表时间:
2010-04-17 - 期刊:
- 影响因子:3.300
- 作者:
William A. Carlezon;Klaus A. Miczek - 通讯作者:
Klaus A. Miczek
Epinephrine: A Short- and Long-Term Regulator of Stress and Development of Illness
- DOI:
10.1007/s10571-011-9768-0 - 发表时间:
2011-11-17 - 期刊:
- 影响因子:4.800
- 作者:
Dona Lee Wong;T. C. Tai;David C. Wong-Faull;Robert Claycomb;Edward G. Meloni;Karyn M. Myers;William A. Carlezon;Richard Kvetnansky - 通讯作者:
Richard Kvetnansky
William A. Carlezon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('William A. Carlezon', 18)}}的其他基金
Training to Enhance Alignment of Psychiatry and Neuroscience
加强精神病学和神经科学协调的培训
- 批准号:
10591484 - 财政年份:2021
- 资助金额:
$ 271.61万 - 项目类别:
Roles of nuleus accumbens CREB and Kappa function in depression
伏隔核 CREB 和 Kappa 功能在抑郁症中的作用
- 批准号:
10687178 - 财政年份:2021
- 资助金额:
$ 271.61万 - 项目类别:
Roles of nuleus accumbens CREB and Kappa function in depression
伏隔核 CREB 和 Kappa 功能在抑郁症中的作用
- 批准号:
10490460 - 财政年份:2021
- 资助金额:
$ 271.61万 - 项目类别:
Training to Enhance Alignment of Psychiatry and Neuroscience
加强精神病学和神经科学协调的培训
- 批准号:
10170928 - 财政年份:2021
- 资助金额:
$ 271.61万 - 项目类别:
Roles of nuleus accumbens CREB and Kappa function in depression
伏隔核 CREB 和 Kappa 功能在抑郁症中的作用
- 批准号:
10380269 - 财政年份:2021
- 资助金额:
$ 271.61万 - 项目类别:
Training to Enhance Alignment of Psychiatry and Neuroscience
加强精神病学和神经科学协调的培训
- 批准号:
10390406 - 财政年份:2021
- 资助金额:
$ 271.61万 - 项目类别:
Silvio O. Conte Center for Stress Peptide Advanced Research, Education, & Dissemination (SPARED) at McLean Hospital
Silvio O. Conte 应激肽高级研究、教育中心,
- 批准号:
10579991 - 财政年份:2019
- 资助金额:
$ 271.61万 - 项目类别:
Roles of CRF-PACAP systems in sleep in mice (Carlezon)
CRF-PACAP 系统在小鼠睡眠中的作用 (Carlezon)
- 批准号:
10356106 - 财政年份:2019
- 资助金额:
$ 271.61万 - 项目类别:
Silvio O. Conte Center for Stress Peptide Advanced Research, Education, & Dissemination (SPARED) at McLean Hospital
Silvio O. Conte 应激肽高级研究、教育中心,
- 批准号:
10376397 - 财政年份:2019
- 资助金额:
$ 271.61万 - 项目类别:
相似海外基金
Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
- 批准号:
10109165 - 财政年份:2024
- 资助金额:
$ 271.61万 - 项目类别:
Launchpad
Integration of stepped care for Perinatal Mood and Anxiety Disorders among Women Living with HIV in Kenya
肯尼亚艾滋病毒感染妇女围产期情绪和焦虑障碍的分级护理一体化
- 批准号:
10677075 - 财政年份:2023
- 资助金额:
$ 271.61万 - 项目类别:
Understanding the Effects of Adolescent Nicotine Exposure on Increased Risk for Mood and Anxiety Disorders: Bridging the Gap from Pre-Clinical to Clinical Investigations
了解青少年尼古丁暴露对情绪和焦虑障碍风险增加的影响:弥合临床前研究与临床研究之间的差距
- 批准号:
478121 - 财政年份:2023
- 资助金额:
$ 271.61万 - 项目类别:
Operating Grants
Addressing perinatal mood and anxiety disorders (PMADs) through a doula intervention
通过导乐干预解决围产期情绪和焦虑障碍 (PMAD)
- 批准号:
10861961 - 财政年份:2023
- 资助金额:
$ 271.61万 - 项目类别:
Evaluation of the effectiveness and implementation of online group cognitive behavioral therapy for perinatal women with anxiety disorders.
评估在线团体认知行为治疗对患有焦虑症的围产期妇女的有效性和实施情况。
- 批准号:
22KJ3164 - 财政年份:2023
- 资助金额:
$ 271.61万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Investigating the error-related negativity and the balance N1 in children with anxiety disorders
调查焦虑症儿童的错误相关消极性和平衡 N1
- 批准号:
10685283 - 财政年份:2022
- 资助金额:
$ 271.61万 - 项目类别:
RESONY: Digital therapeutic to manage anxiety disorders
RESONY:管理焦虑症的数字疗法
- 批准号:
10042996 - 财政年份:2022
- 资助金额:
$ 271.61万 - 项目类别:
Grant for R&D
Augmenting the Efficacy of Benzodiazepine Taper with Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids
通过远程医疗提供的认知行为疗法来增强苯二氮卓类药物逐渐减少的疗效,以治疗使用处方阿片类药物的焦虑症患者
- 批准号:
10705005 - 财政年份:2022
- 资助金额:
$ 271.61万 - 项目类别:
Developing an adjunctive mobile application for co-morbid substance use and anxiety disorders: comprehensive user experience testing of the Unwinding Anxiety application
开发针对共病药物使用和焦虑症的辅助移动应用程序:Unwinding Anxiety 应用程序的综合用户体验测试
- 批准号:
10597521 - 财政年份:2022
- 资助金额:
$ 271.61万 - 项目类别:
Investigating the role of neuroinflammation in environmental exposure-induced anxiety disorders
研究神经炎症在环境暴露诱发的焦虑症中的作用
- 批准号:
10573948 - 财政年份:2022
- 资助金额:
$ 271.61万 - 项目类别:














{{item.name}}会员




